Pharmaceutical and Biopharmaceutical Discovery and Manufacturing
Science, Engineering, and Technology
Research and Development
Archive information and mining:
Information mapping
Advanced databases
Cheminformatics
Bioinformatics
Small (APIs) and large molecules (macromolecules)
competitiveness:
Intellectual inventiveness (IP strategy)
Intelligent search and Expert Opinion
Patents (drafts, novelty, litigations)
Mergers and acquisitions
Technology readiness
Innovation and discovery:
Pharmaceutical manufacturing
Biopharmaceutical targets
Drug discovery
Continuous manufacturing
Analytical technologies
Process sensing
Industry 4.0
Enhanced characterization
Particle technology
Crystallization (APIs, soluble and membrane proteins)
Crystal polymorphs
Our passion
Kappa Crystals Ltd was set up in 2019 in Dublin. 'Crystals' is in the name because crystals are truly inspiring due to the properties they provide and physico-chemical characteristics. They attract people from all backgrounds and of all interests. Through crystals, a substance (a basic chemical, material, food ingredient, pharmaceutical, or protein) can be isolated for varying purposes. Yet, this process involves science, engineering, and technology, from the understanding of crystallization to applications, and requires methods, instruments, sensors, and even planning and regulations.
At Kappa Crystals we aim at supporting and accelerating these factors for a wide range of businesses working in pharmaceutical and biopharmaceutical R&D, materials, advanced powder and particles, and food and dairy.
Since a decade, our core members have been working on the design and development of materials, products and methods for the food, chemical, and biotechnological sectors. We can support your ambitions and provide you with novel designs of analytical technologies, scale-up and validation, quality by design (QbD), law and regulations, pharmaceutical and biopharmaceutical discovery, and customized proposals and engineering solutions for the production of crystals and particles including reactors, robots, microfluidics, 3D printing, continuous pipelines, and 2D and 3D imaging algorithms and optical assemblies.